"Tarceva '(erlotinib): Farashin takwarorinsu. Kamar yadda mai rahusa saya a "Tarceva"

Drug "Tarceva", ko kuma wajen, ta babban aiki sashi - erlotinib - shi ne mai m hanawa na tyrosine kinase. Wannan enzyme ne ba a cikin epidermal girma factor tsoka mai amsa sigina HER1 / EGFR, tarewa da kuma taimaka jinkirta ci gaban da m siffofin maruran.

A cewar 'yan karatu, da yin amfani da "Tarceva" miyagun ƙwayoyi mika rayuwar marasa lafiya da metastatic huhu ciwon daji ne kusan 42%. Bugu da kari, da miyagun ƙwayoyi rage bayyanuwar cututtuka da suka shafi wannan Pathology - tari, zafi da wahala numfashi.

Da miyagun ƙwayoyi da aka saki kawai a kan takardar sayen magani. Yana za a iya saya a kantin magani cibiyar sadarwa, amma yana da daraja da shi sosai. A Generic "Tarceva» - Erlonat da Erlocip, samar ƙarƙashin lasisi daga cikin shahararrun Indian kamfanonin Natco Pharna Ltd. kuma Cipla Ltd., suna da yawa mai rahusa.

Inda zai yiwu miyagun ƙwayoyi "Tarceva" saya mai rahusa

A Rasha, da Generic "Tarceva" ta shahara Indian masana'antun suna samuwa a wani musamman website tare da manyan India kamfanin 5 shekara suna WWW.ONKO24.COM. Terms of Service - kasancewa na dacewa da takardun, wanda za a iya tabbatar da bukatar wani zamani magani.

Generics Allunan "Tarceva" da farashin da aka ba rage saboda gaskiyar cewa wadannan kwayoyi ne da ɗan baya zuwa iri-sunan. Su ake samar bisa ga hukuma lasisi da kuma karkashin tsauraran ingancin iko. Kawai Indian hukumomi ba su da su zuba jari a fasahar ci gaba da kuma gudanar da bincike. Kuma cewa, a karshen shi ne iya taimakawa wajen fitar da talakawa saye a wuya rayuwa halin da ake ciki. Saboda haka, umurnin Generic kayan aikin "Tarceva" a kan wannan shafin, kada ka ji tsoro, zai samu wani karya ne!

Dosing da kashi shiri

Yana nufin dauka baki, sa'a daya kafin ko bayan 2 hours bayan da abinci, sau daya a rana.

Dangane da ganewar asali, yana nufin "Tarceva" sashi jeri:

• a cikin hali na ba-kananan cell huhu ciwon daji - 150 MG (da kashi).
• bisa ganewa na pancreatic ciwon daji aka wajabta 100 MG, a hade tare da wani shiri dauke da gemcitabine.

Idan dole, gyara ne a hankali rage kashi da 50 MG.

Lokacin da cutar progresses da bayyanar cututtuka na magani nufin "Tarceva" dole ne a daina.

Erlotinib ( 'Tarceva') a cikin wani kashi wucewa da shawarar zai iya sa haƙuri fata rashes, zawo da kuma haifar da ƙãra matakan da hanta enzymes. Wadannan cututtuka bukatar symptomatic far da kuma lura da "Tarceva" a wannan lokacin da aka dakatar.

contraindications

Wannan kayan aiki ne ba wajabta gano tsanani alerji zuwa erlotinib. "Tarceva" an kuma ba a nuna domin ciki ko lactating.

Masana sun dole ne m assigning shiri tare da mahaukaci hanta aiki, kuma bai kai shekara 18 marasa lafiya.

illa

A cikin aikace-aikace na alluna "Tarceva" ko generics wadannan ba a ke so illa na iya faruwa a marasa lafiya:

• zawo.
• tashin zuciya da kuma amai.
• anorexia.
• epigastric zafi.
• ciki zub da jini (musamman a cikin hali na lokaci daya aikace-aikace "Warfarin" shiri ko NSAIDs).
• conjunctivitis.
• keratitis.
• nosebleeds.
• tari, kuma shortness na numfashi;
• ciwon kai.
• neuropathy.
• bushe fata, itching.
• nauyi asara.

Features na aikace-aikace

Tare da ci gaban bayyanar cututtuka na huhu Pathology (tari, dyspnea, da kuma zazzabi) da miyagun ƙwayoyi "Tarceva" tasha shan domin gano dalilin.

Marasa lafiya da hadarin dehydration zama dole don sarrafa adadin jini Wutan (potassium, musamman), da kuma sa idanu aiki na kodan.

Tun da far da "Tarceva" a wasu lokuta, shi ya haifar da ci gaban hanta gazawar, sa'an nan a ko'ina cikin shakka ya kamata a kula ga hanta aiki, musamman a cikin wadanda marasa lafiya da suke da wata cuta, ko ana samun hepatotoxic kwayoyi. A hali mai tsanani hanta lahani liyafar "Tarceva" na nufin tasha.

Amfani da miyagun ƙwayoyi ne ba zai yiwu a yanayin saukan gastrointestinal perforation a gaban exfoliative ko bullous fata raunuka, kazalika idan akwai zafi a cikin idanu ko exacerbation na ocular pathological tafiyar matakai.

A lokacin jiyya tsari, kuma ba kasa da kwanaki 14 bayan da mata bukatar m hana.